Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0036 | 0.2562 | 0.4819 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Echinococcus granulosus | dna polymerase eta | 0.0051 | 0.5316 | 0.5316 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.5316 | 0.5703 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0022 | 0.0045 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.9322 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0051 | 0.5316 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0022 | 0.0045 | 0.0048 |
Onchocerca volvulus | 0.0051 | 0.5373 | 0.5 | |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0073 | 0.9322 | 0.9322 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0022 | 0.0045 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0051 | 0.5316 | 0.5703 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0022 | 0.0045 | 0.0045 |
Echinococcus multilocularis | dna polymerase eta | 0.0051 | 0.5316 | 0.5316 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0073 | 0.9322 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0022 | 0.0045 | 0.0045 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Leishmania major | DNA polymerase eta, putative | 0.0036 | 0.2562 | 0.4819 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0022 | 0.0045 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0022 | 0.0045 | 0.0045 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.0045 | 0.0084 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0022 | 0.0045 | 0.0084 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0051 | 0.5373 | 0.5764 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0022 | 0.0045 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.0022 | 0.0045 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.5373 | 0.5764 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0022 | 0.0045 | 0.0045 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0051 | 0.5373 | 0.5373 |
Trypanosoma brucei | unspecified product | 0.0022 | 0.0045 | 0.0084 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0022 | 0.0045 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.0045 | 0.0084 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Giardia lamblia | DINP protein human, muc B family | 0.0022 | 0.0045 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0051 | 0.5316 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0036 | 0.2562 | 0.5 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0022 | 0.0045 | 0.0048 |
Schistosoma mansoni | DNA polymerase eta | 0.0051 | 0.5316 | 0.5316 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0022 | 0.0045 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.9322 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0051 | 0.5316 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.0045 | 0.0084 |
Brugia malayi | calpain family protein 1 | 0.0073 | 0.9322 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0022 | 0.0045 | 0.0045 |
Brugia malayi | calpain family protein 1 | 0.0073 | 0.9322 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.5373 | 0.5764 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0022 | 0.0045 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0045 | 0.0084 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.9362 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 21.3313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.